Milada Cvancarova

Oslo University Hospital

Papers

1

Total Citations

9

H-Index

1

About

Milada Cvancarova is a distinguished biostatistician whose research has significantly advanced the methodology for analyzing patient-reported outcomes, particularly in cancer survivorship. Her key contributions lie in developing and refining statistical approaches for prospective studies of adverse effects, with a focus on prostate cancer patients. Her most cited work, a 2011 paper, introduced and compared innovative methods—specifically the Proportions of Patients Regaining 90% of Baseline Function Score (PBS-90) and Generalized Estimating Equations (GEE)—to more accurately capture changes in sexual, urinary, and bowel function after treatment. This methodological framework has been instrumental in moving beyond simple mean comparisons to model individual patient trajectories, offering deeper insights into recovery patterns. With 9 citations, this foundational paper has guided subsequent research in oncology outcomes. Cvancarova’s expertise in longitudinal data analysis has helped clinicians and researchers better understand the real-world impact of treatments like surgery and radiotherapy, ultimately improving patient counseling and care. Her work exemplifies how rigorous statistical methods can translate into meaningful clinical insights, making her a vital contributor to evidence-based survivorship research.

Research Focus

Key Achievements

1
H-Index
1
Papers
9
Total Citations
9
Avg Citations/Paper
🏆 Most Cited Paper
Methods for prospective studies of adverse effects as applied to prostate cancer patients treated with surgery or radiotherapy without hormones
9 citations · 2011
📈 Most Prolific Year: 2011 (1 Papers)
🤝 Key Collaborators: 7
🏛 Institutions: Oslo University Hospital

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 14 days ago